
Ashokkumar B. Patel
Supervisory Patent Examiner (ID: 9363, Phone: (571)272-3972 , Office: P/2491 )
| Most Active Art Unit | 2154 |
| Art Unit(s) | 2456, 2449, 2491, 2154 |
| Total Applications | 276 |
| Issued Applications | 121 |
| Pending Applications | 21 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5609199
[patent_doc_number] => 20060270715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Dosage forms of amlodipine and processes for their preparation'
[patent_app_type] => utility
[patent_app_number] => 10/546114
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4290
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546114 | Dosage forms of amlodipine and processes for their preparation | Feb 26, 2004 | Abandoned |
Array
(
[id] => 7352130
[patent_doc_number] => 20040248939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Stable pharmaceutical compositions comprising acid labile benzimidazoles'
[patent_app_type] => new
[patent_app_number] => 10/487809
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9593
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248939.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487809 | Stable pharmaceutical compositions comprising acid labile benzimidazoles | Feb 25, 2004 | Abandoned |
Array
(
[id] => 7466992
[patent_doc_number] => 20040198788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Medicinal compositions containing angiotensin II receptor antagonist'
[patent_app_type] => new
[patent_app_number] => 10/789340
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4567
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198788.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789340 | Medicinal compositions containing angiotensin II receptor antagonist | Feb 25, 2004 | Abandoned |
Array
(
[id] => 5784216
[patent_doc_number] => 20060204457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor'
[patent_app_type] => utility
[patent_app_number] => 10/546590
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7337
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546590
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546590 | Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor | Feb 24, 2004 | Abandoned |
Array
(
[id] => 7466855
[patent_doc_number] => 20040198774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Preventive and/or remedial agent for disease attributable to arteriosclerotic activity'
[patent_app_type] => new
[patent_app_number] => 10/487492
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4024
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487492 | Preventive and/or remedial agent for disease attributable to arteriosclerotic activity | Feb 22, 2004 | Abandoned |
Array
(
[id] => 7811372
[patent_doc_number] => 08133903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie\'s disease, arteriosclerosis and other fibrotic diseases'
[patent_app_type] => utility
[patent_app_number] => 10/779069
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 38845
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133903.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779069 | Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases | Feb 12, 2004 | Issued |
Array
(
[id] => 5700749
[patent_doc_number] => 20060217434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Remedy for viral disease'
[patent_app_type] => utility
[patent_app_number] => 10/544896
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18717
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217434.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544896 | Remedy for viral disease | Feb 11, 2004 | Issued |
Array
(
[id] => 356385
[patent_doc_number] => 07488822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-10
[patent_title] => 'Cyclocarbamate derivatives as progesterone receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/767813
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37100
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/488/07488822.pdf
[firstpage_image] =>[orig_patent_app_number] => 10767813
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/767813 | Cyclocarbamate derivatives as progesterone receptor modulators | Jan 28, 2004 | Issued |
Array
(
[id] => 7034240
[patent_doc_number] => 20050032750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Treating androgen deficiency in female (ADIF)-associated conditions with SARMS'
[patent_app_type] => utility
[patent_app_number] => 10/759538
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16984
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10759538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759538 | Treating androgen deficiency in female (ADIF)-associated conditions with SARMS | Jan 19, 2004 | Abandoned |
Array
(
[id] => 7260841
[patent_doc_number] => 20050144146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Pharmaceutical activity and manufacturing method of four kinds of plant compound production of reducing phlegm'
[patent_app_type] => utility
[patent_app_number] => 10/745817
[patent_app_country] => US
[patent_app_date] => 2003-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7671
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20050144146.pdf
[firstpage_image] =>[orig_patent_app_number] => 10745817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/745817 | Pharmaceutical activity and manufacturing method of four kinds of plant compound production of reducing phlegm | Dec 28, 2003 | Abandoned |
Array
(
[id] => 173557
[patent_doc_number] => 07658936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Cosmetic or dermatological impregnated cloths'
[patent_app_type] => utility
[patent_app_number] => 10/745066
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10886
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/658/07658936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10745066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/745066 | Cosmetic or dermatological impregnated cloths | Dec 21, 2003 | Issued |
Array
(
[id] => 7024976
[patent_doc_number] => 20050019370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Implantable device and use therefor'
[patent_app_type] => utility
[patent_app_number] => 10/741421
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14034
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741421
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741421 | Implantable device and use therefor | Dec 18, 2003 | Abandoned |
Array
(
[id] => 7307666
[patent_doc_number] => 20040142043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Sustained-release compositions for injection and process for producing the same'
[patent_app_type] => new
[patent_app_number] => 10/480929
[patent_app_country] => US
[patent_app_date] => 2003-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10272
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480929
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480929 | Sustained-release compositions for injection and process for producing the same | Dec 15, 2003 | Abandoned |
Array
(
[id] => 7181389
[patent_doc_number] => 20050124694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Method of accelerating metabolism of alcohol'
[patent_app_type] => utility
[patent_app_number] => 10/731802
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3707
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10731802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/731802 | Method of accelerating metabolism of alcohol | Dec 8, 2003 | Abandoned |
Array
(
[id] => 7674599
[patent_doc_number] => 20040127519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/728460
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 51539
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127519.pdf
[firstpage_image] =>[orig_patent_app_number] => 10728460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/728460 | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors | Dec 4, 2003 | Abandoned |
Array
(
[id] => 7290953
[patent_doc_number] => 20040110729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Primary N-hydroxylamines'
[patent_app_type] => new
[patent_app_number] => 10/722820
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19098
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10722820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/722820 | Primary N-hydroxylamines | Nov 24, 2003 | Abandoned |
Array
(
[id] => 4493742
[patent_doc_number] => 07956091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Use of carnitines for the prevention and/or treatment of disorders caused by the andropause'
[patent_app_type] => utility
[patent_app_number] => 10/535509
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6957
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956091.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535509 | Use of carnitines for the prevention and/or treatment of disorders caused by the andropause | Nov 19, 2003 | Issued |
Array
(
[id] => 7469423
[patent_doc_number] => 20040167229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Method of lowering CRP and reducing systemic inflammation'
[patent_app_type] => new
[patent_app_number] => 10/712859
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13676
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712859 | Method of lowering CRP and reducing systemic inflammation | Nov 12, 2003 | Abandoned |
Array
(
[id] => 7677185
[patent_doc_number] => 20040152641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Use of polymethoxylated flavones for treating insulin resistance'
[patent_app_type] => new
[patent_app_number] => 10/697563
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4588
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152641.pdf
[firstpage_image] =>[orig_patent_app_number] => 10697563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/697563 | Use of polymethoxylated flavones for treating insulin resistance | Oct 30, 2003 | Abandoned |
Array
(
[id] => 7379889
[patent_doc_number] => 20040081625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Nasal formulations for the treatment of allergies'
[patent_app_type] => new
[patent_app_number] => 10/690233
[patent_app_country] => US
[patent_app_date] => 2003-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2064
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20040081625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10690233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/690233 | Nasal formulations for the treatment of allergies | Oct 20, 2003 | Abandoned |